Evidence map›Paper›PMID 25432002›Full record

ArticleThe Permanente journal2015

Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: a potential use in guiding antibiotic therapy for pneumonia.

Jennifer A Johnson, Michael E Wright, Lyndsay A Sheperd, Daniel M Musher, Bich N Dang

Abstract read
In one paragraph

Article in The Permanente journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Evaluation of a Pharmacist-Led Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  4. Evaluating the Role ofThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2021
    Article
  5. Article
  6. Article
  7. Management of methicillin-resistantCurrent trends in microbiology · 2018
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Jennifer A JohnsonPulmonary and Critical Care Physician at Centennial Medical Center in Nashville, TN. jennifer03johnson@yahoo.com.
Michael E WrightClinical Pharmacist at Williamson County Medical Center in Franklin, TN. michaelwright54@hotmail.com.
Lyndsay A SheperdClinical Pharmacist at Texas Health Presbyterian Hospital in Dallas, TX. LyndsaySheperd@texashealth.org.
Daniel M MusherProfessor of Medicine in the Section of Infectious Diseases at Baylor College of Medicine in Houston, TX. daniel.musher@va.gov.
Bich N DangAssistant Professor of Medicine in the Section of Infectious Diseases at Baylor College of Medicine in Houston, TX. bndang@bcm.edu.
Baylor College of Medicine · USCentennial Medical Center · USTexas Health Dallas · USWilliamson College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe role at admission of nasal polymerase chain reaction (PCR) for patients with methicillin-resistant Staphylococcus aureus (MRSA) in guiding antibiotic therapy for lower respiratory tract infection is unknown.

objectiveTo determine whether nasal MRSA PCR at admission can predict the absence of MRSA in lower respiratory tract secretions.

designWe performed a retrospective study of adult patients admitted to a large urban hospital. Patients had a nasal MRSA PCR test and a lower respiratory tract culture obtained within 48 hours of admission and the culture yielded S aureus.

main outcome measuresSensitivity, specificity, and positive and negative predictive values.

resultsOur results showed high sensitivity (93.3%) and negative predictive value (95.2%) of nasal PCR for MRSA in the lower respiratory tract.

conclusionWith its high sensitivity and negative predictive value, a nasal MRSA PCR test performed within 48 hours of hospital admission could help guide the discontinuation of MRSA-directed empiric antibiotic therapy in patients who are unlikely to be infected with this organism. A prospective study is needed to confirm these findings.

Indexed as

AdultAgedAnti-Bacterial AgentsCarrier StateFemaleHospitals, UrbanHumansMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedNasal CavityPneumonia, StaphylococcalPolymerase Chain ReactionPredictive Value of TestsProspective StudiesRetrospective StudiesAnti-Bacterial Agents

Identifiers

PMID25432002
PMCPMC4315374
OpenAlexW2132054853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.